Overexpression of cyclin D1 and cyclin E in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis

Carcinogenesis

Volumn 17, Issue 8, 1996, Pages 1583-1588

  Wang, Qian Shu ^a   Sabourin, Carol L K ^a   Wang, Hong ^a   Stoner, Gary D ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; MESSENGER RNA; N BENZYL N METHYLNITROSAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ESOPHAGUS MUCOSA; ESOPHAGUS TUMOR; GENE INDUCTION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029741324     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.8.1583     Document Type: Article

References (56)

1. Morgan, D.O. (1992) Cell cycle control in normal and neoplastic cells. Curr. Opin. Genet. Dev., 2, 33-37.
2. Norbury, C. and Nurse, P. (1992) Animal cell cycles and their control. Annu. Rev. Biochem., 61, 441-470.
3. cdc2: the S and M kinase? New Biol., 2, 389-401.
4. Reed, S.I. (1992) The role of p34 kinases in the G1 to S-phase transition. Annu. Rev. Cell Biol., 8, 529-561.
5. Pardee, A.B. (1989) G1 events and regulation of cell proliferation. Science, 246, 603-608.
6. Reed, S.I. (1991) G1-specific cyclins: in search of an S-phase-promoting factor. Trends Genet., 7, 95-99.
7. Bartkova, J., Lukas, J., Müller, H., Strauss, M., Gusterson, B. and Bartek, J. (1995) Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res., 55, 949-956.
8. Keyomarsi, K. and Pardee, A.B. (1993) Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl Acad. Sci. USA, 90, 1112-1116.
9. Sherr, C.J. (1993) Mammalian G1 cyclins. Cell, 73, 1059-1065.
10. Motokura, T., Bloom, T., Kim, H.G., Juppner, H., Ruderman, J.V., Kronenberg, H.M. and Arnold, A. (1991) A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature, 350, 512-515.
11. de Boer, C.J., Loyson, S., Kluin, P.M., Kluin-Nelemans, H.C., Schuuring, E. and van Krieken, J.H. (1993) Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: rearrangements of the cyclin D1 gene. Cancer Res., 53, 4148-4152.
12. Gillett, C., Fantl, V., Smith, R., Fisher, C., Bartek, J., Dickson, C., Barnes, D. and Peters, G. (1994) Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res., 54, 1812-1817.
13. Zhang, Y.-J., Jiang, W., Chen, C.J., Lee, C.S., Kahn, S.M., Santella, R.M. and Weinstein, I.B. (1993) Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun., 196, 1010-1016.
14. Jiang, W., Kahn, S.M., Tomita, N., Zhang, Y.J., Lu, S.H. and Weinstein, I.B. (1992) Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res., 52, 2980-2983.
15. Said, T.K., Luo, L. and Medina, D. (1995) Mouse mammary hyperplasias and neoplasias exhibit different patterns of cyclin D1 and D2 binding to cdk4. Carcinogenesis, 16, 2507-2513.
16. Bianchi, A.B., Fischer, S.M., Robles, A.I., Rinchik, E.M. and Conti, C.J. (1993) Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene, 8, 1127-1133.
17. Robles, A.I. and Conti, C.J. (1995) Early overexpression of cyclin D1 protein in mouse skin carcinogenesis. Carcinogenesis, 16, 781-786.
18. Leach, F.S., Elledge, S.J., Sherr, C.J., Willson, J.K.V., Markowitz, S., Kinzler, K.W. and Vogelstein, B. (1993) Amplification of cyclin genes in colorectal carcinomas. Cancer Res., 53, 1986-1989, 1993.
19. Keyomarsi, K., O'Leary, N., Molnar, G., Lees, E., Fingert, H.J. and Pardee, A.B. (1994) Cyclin E, a potential prognostic marker for breast cancer. Cancer Res., 54, 380-385.
20. Said, T.K. and Medina, D. (1995) Cell cyclins and cyclin-dependent kinase activities in mouse mammary tumor development. Carcinogenesis, 16, 823-830.
21. Sgambato, A., Han, E.K.-H., Zhang, Y.-J., Moon, R.C., Santella, R.M. and Weinstein, I.B. (1995) Deregulated expression of cyclin D1 and other cell cycle-related genes in carcinogen-induced rat mammary tumors. Carcinogenesis, 16, 2193-2198.
22. Parkin, D.M., Stjernsward, J. and Muir, C.S. (1984) Estimates of the worldwide frequency of twelve major cancers. Bull. World Hlth Org., 62, 163.
23. Stoner, G.D. and Rustgi, A.K. (1995) Biology of esophageal squamous cell carcinoma. In Rustgi, A.K. (ed.), Gastrointestinal Cancer: Biology, Diagnosis and Therapy. Lippincott-Raven, Philadelphia, PA, pp. 141-148.
24. Yang, C.S. (1980) Research on esophageal cancer in China: a review. Cancer Res., 40, 2633-2644.
25. Warwick, G.P. and Harington, J.S. (1973) Some aspects of the epidemiology and etiology of esophageal cancer with particular emphasis on the Transkei, South Africa. Adv. Cancer Res., 17, 81-229.
26. Druckrey, H. (1972) Organospecific carcinogenesis in the digestive tract. In Nakahara, W. et al. (eds), Topics in Chemical Carcinogenesis. University Park Press, Baltimore, MD, pp. 73-101.
27. Wang, Y., You, M., Reynolds, S.H., Stoner, G.D. and Anderson, M.W. (1990) Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine. Cancer Res., 50, 1591-1595.
28. Barch, D.H., Jacoby, R.F., Brasitus, T.A., Radosevich, J.A., Carney, W.P. and Iannaccone, P.M. (1991) Incidence of Harvey ras oncogene point mutations and their expression in methylbenzylnitrosamine-induced esophageal tumorigenesis. Carcinogenesis, 12, 2373-2377.
29. Lozano, J.-C., Nakazawa, H., Cros, M.-P., Cabral, R. and Yamasaki, H. (1994) G-A Mutations in p53 and Ha-ras genes in esophageal papillomas induced by N-nitrosomethylbenzylamine in two strains of rats. Mol. Carcinogen., 9, 33-39.
30. Stoner, G.D., Mandal-Chaudhuri, S., Daniel, E.M., Heur, Y.-H. and Morrissey, D.T. (1992) Chemoprevention of esophageal cancer by ellagic acid and phenethyl isothiocyanate. In Wattenberg, L.W., Lipkin, M., Boone, C.W. and Kelloff, G.J. (eds), Cancer Chemoprevention. CRC Press, Boca Raton, FL, pp. 407-439.
31. Murphy, L.D., Herzog, C.E., Rudick, J.B., Fojo, A.T. and Bates, S.E. (1990) Use of polymerase chain reaction in the quantitation of mdr-1 gene expression. Biochemistry, 29, 10351-10356.
32. Horikoshi, T., Danenberg, K.D., Stadlbauer, M.V. et al. (1992) Quantitation of the thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res., 52, 108-116.
33. Kellogg, D.E., Rybalkin, I., Chen, S., Mukhamedova, N., Vlasik, T., Siebert, P.D. and Chenchik, A. (1994) TaqStart antibody: hot start PCR facilitated by a neutralizing monoclonal antibody directed against Taq DNA polymerase. BioTechniques, 16, 1134-1137.
34. Sardelli, S. (1993) Amplifications: A Forum for PCR Users. Perkin-Elmer Cetus, Norwalk, CT, vol. 9, pp. 3-5.
35. Tamura, K., Kanaoka, Y., Jinno, S., Nagata, A., Ogiso, Y., Shimizu, D., Hayakawa, T., Nojima, H. and Okayama, H. (1993) Cyclin G: a new mammalian cyclin with homology to fission yeast cig1. Oncogene, 8, 2113-2118.
36. Matsumoto, K., Moriuchi, T., Koji, T. and Nakane, P.K. (1987) Molecular cloning of cDNA coding for rat proliferating cell nuclear antigen (PCNA)/ cyclin. EMBO J., 6, 637-642.
37. Jansen, J.G., Vrieling, H., van Zeeland, A.A. and Mohn, G.R. (1992) The gene encoding hypoxanthine-guanine phosphoribosyltransferase as target for mutational analysis: PCR cloning and sequencing of the cDNA from the rat. Mutat. Res., 266, 105-116.
38. Lane, K.B., Zoia, O. and Davidson, J.M. (1992) Semi-dry electrophoretic transfer of RNA to membranes. BioTechniques, 12, 340.
39. Napalkov, N.P. and Pozharisski, K.M. (1969) Morphogenesis of experimental tumors of the esophagus. J. Natl Cancer Inst., 42, 922-940.
40. Stinson, S.F., Squire, R.A. and Sporn, M.B. (1978) Pathology of esophageal neoplasms and associated proliferative lesions induced in rats by N-methyl-N-benzylnitrosamine. J. Natl Cancer Inst., 61, 1471-1475.
41. Naitoh, H., Shibata, J., Kawaguchi, A., Kodama, M. and Hattori, T. (1995) Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am. J. Pathol., 146, 1161-1169.
42. Jares, P., Fernández, P.L., Campo, E., Nadal, A., Bosch, F., Aiza, G., Nayach, I., Traserra, J. and Cardesa, A. (1994) PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res., 54, 4813-4817.
43. Mitsunaga, S.I., Zhang, S.Y., Ruggeri, B.A., Gimenez-Conti, I., Robles, A.I., Conti, C.J. and Klein-Szanto, A.J.P. (1995) Positive immunohistochemical staining of p53 and cyclin D in advanced mouse skin tumors, but not in precancerous lesions produced by benzo[a]pyrene. Carcinogenesis, 16, 1629-1635.
44. Filmus, J., Robles, A.I., Shi, W., Wong, M.J., Colombo, L.L. and Conti, C.J. (1994) Induction of cyclin D1 overexpression by activated ras. Oncogene, 9, 3627-3633.
45. Bodrug, S.E., Warner, B.J., Bath, M.L., Lindeman, G.J., Harris, A.W. and Adams, J.M. (1994) Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J., 13, 2124-2130.
46. Ruggeri, B.A., Bauer, B., Zhang, S.-Y. and Klein-Szanto, A.J.P. (1994) Murine squamous cell carcinoma cell lines produced by a complete carcinogenesis protocol with benzo[a]pyrene exhibit characteristic p53 mutations and the absence of H-ras and cyl1/cyclin D1 abnormalities. Carcinogenesis, 15, 1613-1619.
47. Quintanilla, M., Brown, K., Ramsden, M. and Balmain, A. (1986) Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature, 322, 78-80.
48. Roop, D.R., Lowy, D.R., Tambourin, P.E., Strickland, L., Harper, J.R., Balaschak, M., Spangler, E.F. and Yuspa, S.H. (1986) An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue. Nature, 323, 822-824.
49. DiGiovanni, J., Beltran, L., Rupp, A., Harvey, R.G. and Gill, R.D. (1993) Further analysis of c-Ha-ras mutations in papillomas initiated by several polycyclic aromatic hydrocarbons and papillomas from uninitiated, promoter-treated skin in SENCAR mice. Mol. Carcinogen., 8, 272-279.
50. Pestell, R. and Watanabe, G. (1995) Cyclin D1: regulation of expression and its role in tumor formation. J. Robert H. Lurie Cancer Center. 4, 83-90.
51. Bravo, R., Flank, R., Blundell, P.A. and Macdonaldo-Bravo, H. (1987) Cyclin/ PCNA is the auxiliary protein of DNA polymerase δ. Nature (Lond.), 326, 515-517.
52. van Dierendonck, J.H., Wijsman, J.H., Keijzer, R., van de Velde, C.J.H. and Cornelisse, C.J. (1991) Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Am. J. Pathol., 138, 1165-1172.
53. Dutta, A., Chandra, R., Leiter, L.M. and Lester, S. (1995) Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer. Proc. Natl Acad. Sci. USA, 92, 5386-5390.
54. Jiang, W., Kahn, S.M., Zhou, P., Zhang, Y.-J., Cacace, A.M., Infante, A.S., Doi, S., Santella, R.M. and Weinstein, I.B. (1993) Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene, 8, 3447-3457.
55. Ohtsubo, M. and Roberts, J.M. (1993) Cyclin-dependent regulation of G1 in mammalian cells. Science, 259, 1908-1912.
56. Resnitzky, D., Gossen, M., Bujard, H. and Reed, S.I. (1994) Acceleration of the G1/S phase transition by expression of cyclin D1 and E with an inducible system. Mol. Cell. Biol., 14, 1669-1679.